Jonathan Brammer
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma (NCT07356245) | Jonathan Brammer | 2026-02-12 |
| Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia (NCT05592015) | Jonathan Brammer | 2023-05-03 |
| Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic Leukemia (NCT05141682) | Jonathan Brammer | 2022-06-29 |
Track Jonathan Brammer automatically
Every clearance here is in the API, with alerts when new ones post.